<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1994 (9) TMI 160 - CEGAT, NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=83586</link>
    <description>Bulk-drug exemption under Notification No. 31/88-C depended on proof that the goods satisfied the prescribed bulk-drug meaning and pharmacopoeial standard under the Drugs (Price Control) Order, 1987; mere inclusion in the Merck Index or a Drug Controller certificate was not enough without satisfactory chemical or other evidence. End-use certificates were not an invariable precondition, because the later Board circular confined that requirement to the other bulk drugs in the annexed list and three products were already covered by the Second Schedule. The exemption therefore turned on compliance with the bulk-drug and standard requirements, not on a blanket end-use certificate condition.</description>
    <language>en-us</language>
    <pubDate>Fri, 09 Sep 1994 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 14 Jul 2011 13:07:25 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=120731" rel="self" type="application/rss+xml"/>
    <item>
      <title>1994 (9) TMI 160 - CEGAT, NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=83586</link>
      <description>Bulk-drug exemption under Notification No. 31/88-C depended on proof that the goods satisfied the prescribed bulk-drug meaning and pharmacopoeial standard under the Drugs (Price Control) Order, 1987; mere inclusion in the Merck Index or a Drug Controller certificate was not enough without satisfactory chemical or other evidence. End-use certificates were not an invariable precondition, because the later Board circular confined that requirement to the other bulk drugs in the annexed list and three products were already covered by the Second Schedule. The exemption therefore turned on compliance with the bulk-drug and standard requirements, not on a blanket end-use certificate condition.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Fri, 09 Sep 1994 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=83586</guid>
    </item>
  </channel>
</rss>